Article in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Erin S GloagDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA.ORCID 0000-0001-8895-3444
Christopher W MarshallDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, USA.ORCID 0000-0001-6669-3231
Nanami KubotaDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Stacie E DeaverDepartment of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA.
Brennan DeshotelDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, USA.
Vaughn S CooperDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0001-7726-0765
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-4592-4816
Funding
Drug resistance enablers and their role in antibiotic treatment failureU19AI158076 · NIAID · BROAD INSTITUTE, INC. · PI VAN OPIJNEN, TIM · 2022 to 2025
$10.0M
Cooperation and antagonism in polymicrobial infectionR01AI186380 · NIAID · OHIO STATE UNIVERSITY · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2024 to 2026
$2.2M
AHA Career Development Award 19CDA34630005NIH HHS U19AI158076NIH PHS R01AI186380
6 · The paper itself
Abstract
IMPORTANCE: We demonstrate that in a porcine full-thickness thermal injury wound model, a
Indexed as
BiofilmsPersistent InfectionPseudomonas aeruginosaPseudomonas InfectionsAnimalsBacterial ProteinsFimbriae, BacterialLipopolysaccharidesMutationPolysaccharides, BacterialSwineWhole Genome SequencingBacterial ProteinsLipopolysaccharidesPolysaccharides, Bacterialadaptationbiofilmfilamentous phagelipopolysaccharidetype IV pili
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.